These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 36016629)

  • 81. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.
    Chan MY; She WH; Dai WC; Tsang SHY; Chok KSH; Chan ACY; Fung J; Lo CM; Cheung TT
    Transl Gastroenterol Hepatol; 2019; 4():52. PubMed ID: 31463411
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B.
    Yu L; Liu X; Wang X; Dang Z; Jiang Y; Wang X; Yang Z
    J Cancer; 2019; 10(18):4237-4244. PubMed ID: 31413742
    [No Abstract]   [Full Text] [Related]  

  • 83. The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer.
    Wei L; Xie H; Wang Q; Tang S; Gan J
    Front Physiol; 2024; 15():1369855. PubMed ID: 38487266
    [No Abstract]   [Full Text] [Related]  

  • 84. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
    She WH; Chan ACY; Cheung TT; Lo CM; Chok KSH
    World J Hepatol; 2018 Feb; 10(2):308-318. PubMed ID: 29527266
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
    Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
    J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
    [No Abstract]   [Full Text] [Related]  

  • 86. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
    Zang Y; Long P; Wang M; Huang S; Chen C
    Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
    [No Abstract]   [Full Text] [Related]  

  • 88. A novel nomogram based on the prognostic nutritional index for predicting postoperative outcomes in patients with stage I-III gastric cancer undergoing robotic radical gastrectomy.
    Shen D; Zhou G; Zhao J; Wang G; Jiang Z; Liu J; Wang H; Deng Z; Ma C; Li J
    Front Surg; 2022; 9():928659. PubMed ID: 36386538
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
    Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy.
    Wu T; Zheng Z; Wang J; He M; Wang J; Pan Y; Chen J; Hu D; Zhang Y; Xu L; Chen M; Zhou Z
    J Hepatocell Carcinoma; 2023; 10():2133-2145. PubMed ID: 38058386
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
    Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
    World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study.
    Liu X; Qiu Z; Ndhlovu E; Wan Y; Sun H; Wang S; Cao Y; Zhu P
    J Hepatocell Carcinoma; 2024; 11():1127-1141. PubMed ID: 38895590
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.
    Ma L; Deng K; Zhang C; Li H; Luo Y; Yang Y; Li C; Li X; Geng Z; Xie C
    Front Oncol; 2022; 12():843589. PubMed ID: 35296018
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A new model based inflammatory index and tumor burden score (TBS) to predict the recurrence of hepatocellular carcinoma (HCC) after liver resection.
    Wang J; Chen Z; Wang L; Feng S; Qiu Q; Chen D; Li N; Xiao Y
    Sci Rep; 2022 May; 12(1):8670. PubMed ID: 35606395
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
    Zhang D; Zeng H; Pan Y; Zhao Y; Wang X; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Chen M; Hu D
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556261
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.